Your browser doesn't support javascript.
loading
The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.
Bornhauser, Beat; Cario, Gunnar; Rinaldi, Anna; Risch, Thomas; Rodriguez Martinez, Virginia; Schütte, Moritz; Warnatz, Hans-Jörg; Scheidegger, Nastassja; Mirkowska, Paulina; Temperli, Martina; Möller, Claudia; Schumich, Angela; Dworzak, Michael; Attarbaschi, Andishe; Brüggemann, Monika; Ritgen, Mathias; Mejstrikova, Ester; Hofmann, Andreas; Buldini, Barbara; Scarparo, Pamela; Basso, Giuseppe; Maglia, Oscar; Gaipa, Giuseppe; Skoblyn, Tessa-Lara; Te Kronnie, Geertruij; Vendramini, Elena; Panzer-Grümayer, Renate; Barz, Malwine Jeanette; Marovca, Blerim; Hauri-Hohl, Mathias; Niggli, Felix; Eckert, Cornelia; Schrappe, Martin; Stanulla, Martin; Zimmermann, Martin; Wollscheid, Bernd; Yaspo, Marie-Laure; Bourquin, Jean-Pierre.
Afiliación
  • Bornhauser B; Department of Oncology, University Children's Hospital Zurich and Children's Research Center, Zurich, Switzerland.
  • Cario G; Department of Pediatrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Rinaldi A; Department of Oncology, University Children's Hospital Zurich and Children's Research Center, Zurich, Switzerland.
  • Risch T; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Rodriguez Martinez V; Department of Oncology, University Children's Hospital Zurich and Children's Research Center, Zurich, Switzerland.
  • Schütte M; Alacris Theranostics, Berlin, Germany.
  • Warnatz HJ; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Scheidegger N; Department of Oncology, University Children's Hospital Zurich and Children's Research Center, Zurich, Switzerland.
  • Mirkowska P; Department of Oncology, University Children's Hospital Zurich and Children's Research Center, Zurich, Switzerland.
  • Temperli M; Department of Oncology, University Children's Hospital Zurich and Children's Research Center, Zurich, Switzerland.
  • Möller C; Department of Oncology, University Children's Hospital Zurich and Children's Research Center, Zurich, Switzerland.
  • Schumich A; St. Anna Children's Hospital and Children's Cancer Research Institute, Vienna, Austria.
  • Dworzak M; St. Anna Children's Hospital and Children's Cancer Research Institute, Vienna, Austria.
  • Attarbaschi A; St. Anna Children's Hospital and Children's Cancer Research Institute, Vienna, Austria.
  • Brüggemann M; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Ritgen M; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Mejstrikova E; Department of Pediatric Hematology and Oncology, Charles University Hospital Motol, Prague, Czech Republic.
  • Hofmann A; Department of Health Sciences and Technology and Institute for Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
  • Buldini B; Department of Women's and Children's Health, University of Padova, Padova, Italy.
  • Scarparo P; Department of Women's and Children's Health, University of Padova, Padova, Italy.
  • Basso G; Department of Women's and Children's Health, University of Padova, Padova, Italy.
  • Maglia O; Italian Institute for Genomic Medicine, Turin, Italy.
  • Gaipa G; M. Tettamanti Research Center, University of Milano Bicocca, Monza, Italy.
  • Skoblyn TL; M. Tettamanti Research Center, University of Milano Bicocca, Monza, Italy.
  • Te Kronnie G; Pediatric Hematology and Oncology, Charité University Hospital, Berlin, Germany.
  • Vendramini E; Department of Women's and Children's Health, University of Padova, Padova, Italy.
  • Panzer-Grümayer R; Department of Women's and Children's Health, University of Padova, Padova, Italy.
  • Barz MJ; St. Anna Children's Hospital and Children's Cancer Research Institute, Vienna, Austria.
  • Marovca B; Department of Oncology, University Children's Hospital Zurich and Children's Research Center, Zurich, Switzerland.
  • Hauri-Hohl M; Department of Oncology, University Children's Hospital Zurich and Children's Research Center, Zurich, Switzerland.
  • Niggli F; Department of Stem Cell Transplantation, University Children's Hospital Zurich, Zurich, Switzerland; and.
  • Eckert C; Department of Oncology, University Children's Hospital Zurich and Children's Research Center, Zurich, Switzerland.
  • Schrappe M; Pediatric Hematology and Oncology, Charité University Hospital, Berlin, Germany.
  • Stanulla M; Department of Pediatrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Zimmermann M; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Wollscheid B; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Yaspo ML; Department of Health Sciences and Technology and Institute for Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
  • Bourquin JP; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Blood Adv ; 4(17): 4052-4064, 2020 09 08.
Article en En | MEDLINE | ID: mdl-32853382

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Blood Adv Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Blood Adv Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos